Alphalytik Pharmaservice
Pre-clinicalAlphalytik Pharmaservice is a specialized service provider offering GMP laboratory analytics and consulting to the pharmaceutical industry, ensuring product integrity and regulatory compliance throughout a drug's lifecycle. Founded in 1995, the company has processed over 3.5 million tablets and completed thousands of projects, building a reputation for precision and reliability. Its mission is to provide clients with maximum safety and compliance through a combination of expert analysis, tailored consulting, and validation services. The company's strategic direction focuses on leveraging deep regulatory expertise and efficient processes to minimize client risk and accelerate product development.
AI Company Overview
Alphalytik Pharmaservice is a specialized service provider offering GMP laboratory analytics and consulting to the pharmaceutical industry, ensuring product integrity and regulatory compliance throughout a drug's lifecycle. Founded in 1995, the company has processed over 3.5 million tablets and completed thousands of projects, building a reputation for precision and reliability. Its mission is to provide clients with maximum safety and compliance through a combination of expert analysis, tailored consulting, and validation services. The company's strategic direction focuses on leveraging deep regulatory expertise and efficient processes to minimize client risk and accelerate product development.
Technology Platform
A service platform centered on GMP-compliant pharmaceutical analytics, method validation, and regulatory consulting, utilizing a comprehensive suite of analytical techniques and deep expertise in global quality standards to support drug development and manufacturing.
Funding History
1Total raised: $2M
Opportunities
Risk Factors
Competitive Landscape
Competes with large global CROs (e.g., LabCorp, IQVIA) and niche analytical labs. Differentiation is based on deep, specialized expertise in European GMP standards, a focus on pharmaceutical analytics (not broad clinical research), and likely greater agility and personalized service as a mid-sized, established German provider.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile